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Encodamers: Unnatural Peptide
Oligomers Encoded in RNA
cern for host viability [9]. Additionally, these in vitro dis-
play approaches allow even a single functional molecule
to be isolated from vast molecular libraries, since the
Adam Frankel,1 Steven W. Millward,1
and Richard W. Roberts*
Division of Chemistry and Chemical Engineering
California Institute of Technology, 147-75 encoding information can be amplified by PCR after
each selection cycle. Unnatural amino acids have beenPasadena, California 91125
inserted and selected in mRNA display libraries by non-
sense suppression [10] and sense suppression [11] at
single sites as well as site specifically by chemical deri-Summary
vatization [12]. Creating display libraries that contain
multiple consecutive insertions of unnatural amino acidsConventional display libraries are generally limited to
the 20 naturally occurring amino acids. Here, we dem- represents an important goal in unifying the benefits of
natural and chemically synthesized libraries. The abilityonstrate that novel unnatural amide-linked oligomers
can be constructed and encoded in an attached RNA to generate polypeptides containing two or more unnat-
ural insertions in response to either four base codonsfor the purpose of mRNA display library design. To do
this, we translated templates of various lengths in a [13] or in a reconstituted translation extract [14] repre-
sent important steps in that direction.protein synthesis system modified to promote sense
codon suppression. Unnatural residues were escorted The ability to create trillion member unnatural peptide
libraries with modest chain length (2–12 residues) wouldto the ribosome as chemically acylated tRNAs added
to the translation mixture. Our experiments reveal that facilitate construction and selection of molecules similar
to therapeutically important natural products producedunnatural peptide oligomers (“encodamers”) con-
sisting of an N-substituted amino acid are readily gen- by nonribosomal peptide synthetases (NRPSs) [15, 16].
The natural products that NRPSs generate exhibit aerated as mRNA-peptide fusions with excellent step-
wise efficiency. The N-substituted polyamides have broad range of biological activities, likely resulting from
the structural diversity and chemical complexity thatstrikingly improved proteolytic stability relative to their
naturally encoded counterparts. Overall, our work indi- they contain. These compounds are typically assembled
in vivo by a single multidomain protein in which eachcates that the ribosome can be used as a synthesis
platform to generate encoded combinatorial chemis- domain performs one step in a multistep synthesis. Non-
ribosomal peptides (NRPs) can exhibit good levels oftry outside the universal genetic code.
oral bioavailability despite violating common rules of
thumb [17]. We note that the well-known “rule of five”Introduction
is believed to be a poor predictor of oral bioavailability
in the NRP class [18]. The best-known example is theThe development of therapeutic peptide ligands is an
important application of combinatorial libraries. Tradi- NRP cyclosporin A (trade name “Sandimmune”; molecu-
lar weight, 1203.6 g  mol1), a cyclic undecamer thattionally, peptide ligand discovery has been explored in
two markedly different modes. In biological display li- serves as a clinically important immunosuppressant in
organ transplantation and is 25%–50% orally availablebraries, such as the phage display system, libraries are
constructed from the 20 natural amino acids and dis- [19]. Cyclosporin A acts intracellularly by forming a ter-
nary complex with cyclophilin and calcineurin [20].played in a format where they are topologically associ-
ated with their encoding genetic material [1]. These natu- Seven of the amide linkages in cyclosporin A contain
N-methyl substituents that likely contribute to its proteo-rally constructed display libraries allow billions to
trillions of compounds to be explored [2], but the disad- lytic resistance [21, 22].
Here, we have worked to create unnatural, N-methyl-vantage is that the encoded peptides or proteins are
typically substrates for proteolysis. By contrast, chemi- ated oligomers encoded in a covalently attached RNA.
To do this, we have translated mRNA display templatescally constructed one-bead one-compound libraries [3]
containing two, five, or ten consecutive sense codonscan utilize any unnatural amino acid monomer that can
that can be suppressed by an orthogonal, chemicallybe coupled with reasonable efficiency. This chemical
acylated tRNA. These templates bear a 3 puromycinapproach can confer improved properties, such as pro-
moiety that forms an amide linkage with the nascentteolysis resistance, but typically limits library size to
peptide on the ribosome [2, 8]. Biochemical analysis105 unique compounds and requires deconvolution to
was used to examine the efficiency of synthesis, productidentify the products of selection, a process in which
distribution, and stability of the resulting molecules. Thethe technical difficulty increases with the desired com-
encoded unnatural peptide oligomers or “encodamers”plexity of the library [4].
generated in this study represent a new approach toThe advent of totally in vitro display libraries, including
encoded combinatorial chemistry with a genetic coderibosome display [5, 6], tRNA display [7], and mRNA
of our choosing (Table 1).display [8], open the possibility of creating unnatural
libraries encoded in RNA because sense codons can
Results and Discussionbe suppressed with arbitrary amino acids without con-
Our initial work started with generating polymers of un-*Correspondence: rroberts@caltech.edu
1These authors contributed equally to this work. natural amino acids encoded as mRNA-peptide fusions.
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Table 1. Reassignment of Codons in This Study
Codon Amino Acid tRNA Orthogonal Amino Acid
AUG Met tRNAiMet [46] —
GUA Val tRNAUAC Phe, N-methyl-Phe
GCU Ala tRNAAGC Val, Phe, N-methyl-Phe
This effort requires a subversion of the genetic code to
include unnatural amino acids via codon reassignment
[9]. Previously, we demonstrated efficient sense codon-
mediated incorporation of the unnatural residue biocytin
in a mRNA-peptide fusion at GUA valine codons by using
chemically acylated tRNAs [11]. In that work, in vitro
suppression of sense codons was performed in a rabbit
reticulocyte lysate that was partially depleted of endog-
enous tRNAs via column chromatography [23]. This
modified lysate allows efficient incorporation of unnatu-
ral amino acids at arbitrary codons and synthesis of
corresponding mRNA-peptide fusions containing a sin-
gle unnatural residue. We therefore chose this lysate as
the translation platform to examine creation of mRNA-
peptide fusions containing multiple unnatural amino
acid insertions.
We designed three templates containing two, five, or
ten consecutive GUA valine codons attached to a flexi-
ble DNA linker ending with a 3-puromycin (Figures 1A
and 1B). Translation reactions were then performed with
each of these templates in the depleted extract in the
presence or absence of an N-methyl-phenylalanine-
tRNAUAC, as shown in Figure 1, with the intention of
producing Met(N-methyl-Phe)n polymers covalently
attached through puromycin to their mRNA encoded
messages. The resulting products were purified and
treated with RNase A so that gel mobility analysis could
be used to examine the length and homogeneity of the
fusions.
Figures 2A and 2B indicate that translation products
are formed both in the presence and absence of the
exogenous chemically acylated tRNA. When fusion
products are analyzed by denaturing urea-PAGE, mobil-
ity differences should reflect any variation in the trans-
lated peptide, as all templates contain the same RNase-
resistant F30P linker [8]. This analysis reveals that
products from the 2G and 5G templates are relatively
uniform when N-methyl-Phe tRNAUAC is added to the
translation reaction and that they run with correspond-
ingly lower mobility than the 41P control. This observa-
Figure 1. Suppression Scheme and Templates Usedtion is consistent with the formation of two- and five-
(A) Scheme for inserting N-methyl-phenylalanine into mRNA displayresidue oligopeptides on these templates, respectively.
templates at GUA valine codons. The templates are RNA (black)The 10G template forms a product that appears to ag-
and DNA (gray) chimeras containing the drug puromycin (P) at thegregate, running as a diffuse smear under these condi-
3 end. The unnatural amino acid is escorted to the ribosome via a
tions. This product is distinct from the reaction lacking chemically acyleted suppressor tRNAUAC.
N-methyl-Phe tRNAUAC (lane 6) and consistent with ag- (B) Templates used to examine unnatural incorporation containing
gregation in the longer hydrophobic N-methyl-Phe two (2G), five (5G), or ten (10G) consecutive GUA valine codons.
The control template 41P containing a single AUG methionine codonoligomer.
is also shown.Analysis of the same N-methyl-Phe tRNAUAC reactions
in a peptide-resolving SDS tricine gel (where mobility
depends both on the charged F30P portion and SDS synthesis of two-, five-, and ten-residue N-methyl-Phe
oligomers. When the chemically acylated tRNA is omit-bound to the peptide or linker; Figure 2B) reveals that
distinct and relatively homogeneous products are formed ted, a higher mobility series of bands are observed,
consistent with synthesis of truncated or valine-con-on all of the templates tested. All three migrate with lower
mobilities than the control 41P product, consistent with taining oligomers.
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Figure 2. tRNA-Dependence for Full-Length Encodamer Formation
Templates were translated in the presence or absence of 2 g
N-methyl-Phe-tRNAUAC. Purified [35S]-labeled mRNA-peptide fusions
(10 L) were treated with 1 g RNase A (DNase-free; Qiagen) at
ambient temperature and subsequently run on either 10% Urea- Figure 3. Analysis of Encodamer Resistance to Proteolysis
PAGE (A) or 15% Tricine-PAGE [47] (B) for phosphorimaging. The Templates containing GUA repeats were translated in the presence
arrows indicate full-length encodamers after RNA hydrolysis. or absence of 2 g N-methyl-phenylalanine-tRNAUAC. Purified [35S]-
labeled mRNA-peptide fusions (10 L) were treated with either 1
g RNase A at ambient temperature, 10 g -chymotrypsin for 90
min at 25C with or without RNase A, or 10g proteinase K for 30 minIn an effort to show that poly(GUA) can indeed code
at 37C with or without RNase. Panels (A)–(C) are phosphorimages of
for N-methyl-Phe encodamers, we subjected purified 10% Tricine-PAGE gels for templates 2G, 5G, and 10G, respectively.
fusions to a battery of hydrolytic enzymes whose activi- 41P is shown as a size control.
ties would facilitate the loss of the [35S]Met label in the
event of natural amino acid insertion while preserving
the radiolabel in the unnatural oligomer. Previously, we N-methyl-Phe-tRNAUAC used in the translation of the 5G
template. As shown in Figure 4A, increasing amountshad shown that proteinase K efficiently degrades natural
mRNA peptide fusion products [8]. The inclusion of of exogenous tRNA present in the translation reactions
result in encodamers with higher resistance to protein-N-methyl-Phe-tRNAUAC in the reactions results in proteo-
lytically resistant fusions (Figure 3). Treatment of these ase K digestion. This effect appears to plateau at 2 g
N-methyl-Phe-tRNAUAC and demonstrates that, at higherencodamers with chymotrypsin (apparently containing
RNase activity as purchased; Figure 3, lanes 4–12) gen- concentrations of exogenous tRNA, insertion of the un-
natural amino acid outcompetes natural amino acids forerates the unnatural oligomer attached to its DNA linker,
while treatment with proteinase K (Figure 3, lanes 13–18) the GUA codon with an approximately 30-fold enrich-
ment for proteolysis resistance.and pepsin (data not shown) leave the full-length fusion
intact. These data support the notion that the formation Although it is difficult to comment on the precise level
of unnatural amino acid incorporation at a single GUAof proteolytically stable encodamers is dependent on
the addition of exogenous N-methyl-Phe-tRNAUAC. It codon within the context of the 5G template, we can
consider the encodamer a product of five independentshould be noted that the total amount of radiolabeled
fusion material decreases in all samples treated with a suppression steps (not including AUG coding for methi-
onine). We calculate that the approximately 53% pro-proteolytic enzyme (Figures 3A–3C, lanes 7–18) relative
to samples left untreated (lanes 1–6). This may be the teinase K resistance (Figure 4A) treated as a total prod-
uct yield of a five-step synthesis would imply an 88%result of (1) hydrolysis of the labile L puromycin amide
bond and/or (2) hydrolysis of a population of fusion prod- yield for each step corresponding to N-methyl-Phe in-
corporation at GUA as compared to the natural aminoucts containing one or more valine residues.
The observed slight heterogeneity of products in the acid.
In another titration experiment, we varied the ratio oflonger encodamers (Figures 3B and 3C, lanes 3 and 6)
may be reflective of the quality of the RNA template or N-methyl-Phe-tRNAUAC to either Val-tRNAUAC (Figure 4B)
or Phe-tRNAUAC (Figure 4C) in 5G template translationa result of random valine insertion. To address the latter
possibility, we systematically varied the amount of reactions, while keeping the total tRNAUAC concentration
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Figure 4. Proteolytic Analysis of N-Methyl-Phe Incorporation
(A) The 5G template was translated in the presence of indicated amounts of N-methyl-Phe-tRNAUAC. Purified [35S]-labeled mRNA-peptide
fusions (10 L) were treated with or without 10 g proteinase K for 60 min at 37C as indicated and subsequently run on a 10% Tricine-PAGE
gel for phosphorimaging. The ratios of stable encodamers after proteinase K treatment (lanes 8–14) to the untreated encodamers (lanes 1–7)
were determined by phosphorimaging and are shown in the graph (right).
(B and C) The 5G template was translated in the presence of indicated amounts of N-methyl-Phe-tRNAUAC and either Val-tRNAUAC (B) or Phe-
tRNAUAC (C). The samples were treated as described in (A). The ratios of stable encodamers after proteinase K treatment (lanes 7–12) to the
untreated encodamers (lanes 1–6) were determined by phosphorimaging and are shown in the graphs (right).
constant. As the concentration of N-methyl-Phe-tRNAUAC insertion––would presumably result in the Met(Val)2Ala
(Val)2 fusion. If N-methyl-Phe-tRNAUAC is used, however,was decreased relative to the concentration of Val- or
Phe-tRNAUAC, the amount of fusion products resistant GUA codons should program the insertion of the unnatu-
ral amino acid, leaving GCU to code for Ala. This givesto digestion by proteinase K were reduced below the
41P control. This general trend suggests that the levels us an opportunity to explore the effect a single amino
acid at the GCU position can have on the proteolyticof chemically acylated tRNAs drive competition for
amino acid insertion in our system. Additionally, this stability of the translated 5G* encodamer by suppressing
GCU with different chemically acylated tRNAAGCs. Wedata (Figure 4C) confirms that proteolysis resistance is
indeed a function of N-methyl substitution on phenylala- find that the site-specific incorporation of N-methyl-Phe
at GCU results in a 1.3-fold greater stability over thenine and not a product of suppression per se. We re-
peated this experiment in commercial rabbit reticulocyte open codon and a 2.6-fold greater stability over either
Val or Phe (Figure 5B). These results indicate the relativelysate, yielding similar results (data not shown). This is
not surprising, since a previous selection demonstrated enhancement in proteolysis resistance for N-methyl-Phe
incorporation at a single position within the context ofthat tRNAs recognizing the GUA codon in rabbit reticulo-
cyte lysate can be readily suppressed even without etha- a full-length encodamer.
N-methyl-Phe monomers contain substituents at thenolamine-Sepharose chromatography treatment [11].
To determine the effect on proteolysis resistance of -carbon and the -N-substituted amine that together
provide novel structural diversity. The anomalous solu-a single natural amino acid insertion into the middle
of an N-methyl-Phe encodamer, we designed the 5G* bility characteristics of phenylalanine homopolymers
have been well established and proved useful for Nirenb-template containing a single GCU alanine codon flanked
at either side by two GUA codons. As illustrated in Figure erg and Matthaei almost half a century ago when they
discovered that poly(U) codes for poly(L-Phe) [24]. We5A, translation without chemically acylated tRNAs––
essentially leaving codons “open” for natural amino acid have shown that the longer 10G N-methyl-Phe enco-
Encodamers
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Figure 5. Analysis of Encodamer Synthesis on Nonrepetitive Templates
(A) The 5G* template, which contains a single GCU codon flanked by GUA codons, can be translated in the presence or absence of various
chemically acylated tRNAs. Codon-anticodon pairs in blue represent suppression of GUA valine, and codon-anticodon pairs in red represent
suppression of GCU alanine.
(B) The 5G* template was translated in the presence of 2 g each chemically acylated tRNA indicated. Purified [35S]-labeled mRNA-peptide
fusions (10 L) were treated with or without 10 g proteinase K for 60 min at 37C as indicated and run on a 10% Tricine-PAGE gel for
phosphorimaging. The ratios of stable encodamers after proteinase K treatment (lanes 7–12) to the untreated encodamers (lanes 1–6) were
determined by phosphorimaging and are shown in the graph (right).
damer aggregates on Urea-PAGE despite being linked suppression at sense codons allows for a larger number
of unnatural monomers that can be incorporated into ato the charged F30P linker, whereas the shorter enco-
damers migrate within the gel matrix (Figure 2). In addi- peptide chain.
Fully reconstituted Escherichia coli translation sys-tion to removing H bond donors from the main chain,
appending a methyl group on the amino-nitrogen con- tems have recently been developed to create novel pep-
tides and proteins with chemically acylated tRNAs tofers proteolytic stability for the encoded peptides in line
with previous observations in the NRPs. The generality suppress nonsense [41] and sense codons [14, 42].
These systems, however, have yet to create encodedof this result remains to be examined systematically
across a great variety of sequences. The approach ap- combinatorial libraries. In our eukaryotic translation sys-
tem, ribosome-mediated synthesis of unnatural oligo-plied here to N-methyl-Phe polymers may also be exam-
ined with other interesting classes of monomers, such mers with dramatically reduced susceptibility to proteo-
lytic enzymes can readily be encoded within a mRNAas the N-substituted glycines (NSGs) or “peptoids” that
contain side chains appended to their amide nitrogens display library.
rather than at the -carbon position [25]. The peptoid
class has some attractive properties, including proteo-
lytic resistance [26], the potential for defined secondary Significance
structure, and cell permeability [27–30].
The translation machinery is geared toward accurate Libraries generated by mRNA display can contain
more than 1013 unique molecules from which the se-polymer synthesis and presents the advantages of multi-
ple-site incorporation of a diverse monomer set for en- quences of selected molecules can be easily ex-
tracted. Here, we have extended the complexity ofcoded combinatorial libraries comprised of unnatural
oligomers. The ribosome can accommodate a wide mRNA display libraries beyond the 20 naturally oc-
curring amino acids by subverting the genetic coderange of unnatural amino acids, including those with
novel side chains [31–33] or altered connectivities [34– to include N-methyl-phenylalanine and via codon reas-
signment of valine and alanine. This system is amena-40]. Chamberlin and coworkers were the first to incorpo-
rate N-methyl phenylalanine via nonsense suppression ble to creating completely unnatural polymers or enco-
damers drawing from the diversity of natural andinto peptides translated in rabbit reticulocyte lysate [35].
Surprisingly, this residue was found to have remarkably unnatural amino acids. We demonstrate that the or-
thogonally encoded N-methyl-Phe oligomers trans-high translation efficiency (91% relative to glycine) de-
spite the reduced nucleophilicity of the secondary C lated via mRNA display are resistant to proteolysis, a
useful property that should enhance the stability ofamine. We have determined that the stepwise yield for
N-methyl phenylalanine incorporation in the 5G template high-affinity in vitro-selected compounds in an in vivo
setting. The encodamers described in this study thusis similar (88%) to that found with nonsense suppres-
sion. Unlike nonsense suppression, which is limited to mark an initial step in developing more drug-like com-
pounds from encoded combinatorial display libraries.the addition of a 21st amino acid to the genetic code,
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Experimental Procedures Synthesis of N-Nitroveratrylcarbonyl Valine-dCA
Reaction and purification were performed as described for the syn-
thesis of N-methyl, N-nitroveratrylcarbonyl phenylalanine-dCA.Syntheses
The coupling of N-protected phenylalanine derivatives and other Yield, 2.2% after HPLC purification. Analysis by low-resolution ESI-
MS: expected [M-H], 973.2; observed [M-H], 973.4.amino acids to pdCpA has been described previously [35, 43, 44]
and is outlined below with some minor modifications.
Preparation of Aminoacylated tRNAs
The tRNAs used in this study are based on the THG73 amber sup-
Synthesis of N-Methyl, N-Nitroveratrylcarbonyl
pressor tRNA [45], but they have been mutated to contain different
Phenylalanine Cyanomethyl Ester
anticodon triplets and were prepared as previously described [11].
Approximately 100 mg N-methyl-L-phenylalanine (558 mol) was
Purified tRNAs were ligated to a molar excess of NVOC-protected
dissolved in 2 ml 10% NaCO3 and 1 ml dioxane and cooled to amino acid-dCA conjugates with T4 RNA ligase (New England Bio-
4C in an ice bath. To this, 154 mg (558 mol) 4,5-dimethoxy-2-
labs). Reaction mixtures were extracted in an equal volume of phe-
nitrobenzyl chloroformate (NVOC-Cl) was added in 3.2 ml diox-
nol:CHCl3:isoamyl alcohol (25:21:1, pH 5.0) and precipitated with 2.5ane:THF (1:1). The reaction was stirred at 0C for 1 hr and then 25C
volumes ethanol (20C). After drying, the pellet was resuspended
for 3 hr.
in 1.0 mM sodium acetate (pH 5.2) and adjusted to approximately 40
The reaction mixture was poured into 30 ml water and extracted
M (1.0 mg/mL) for each acylated tRNA (260 nm, 750,000 M1*cm1).twice with 10 ml diethyl ether. The aqueous layer was acidified with
Before adding to translation reactions, tRNAs were deprotected by
concentrated HCl (to pH 2) and then extracted twice with ethyl
a xenon lamp outfitted with a 315 nm cutoff filter for 5 min to remove
acetate. The organic layer was dried over MgSO4 and concentrated the NVOC group.
by rotary evaporation.
The crude product was dissolved in 3 ml dry DMF and 1.5 ml
Generation of mRNA-Peptide Fusionschloracetonitrile. To this, 1.9 ml (13.4 mmol) TEA was added, and
Synthetic RNA/DNA hybrid templates were made by the Californiathe reaction was stirred under nitrogen for 24 hr at 25C. Unreacted
Institute of Technology DNA Synthesis Facility. They include 41Pchloroacetonitrile and solvent were removed by rotary evaporation,
(5-GGAGGACGAA AUG-F30P-3), 2G (5-GGAGGACGAA AUGGUand the product was purified by silica gel chromatography in 95:5
AGUA-F30P-3), 5G (5-GGAGGACGAA AUGGUAGUAG UAGUACH2Cl2:MeOH (Rf, 0.7). Product was obtained as a yellow oil. Yield, GUA-F30P-3), 10G (5-GGAGGACGAA AUGGUAGUAG UAGUAGU73% (185 mg). Analysis by low-resolution ESI-MS: expected
AGU AGUAGUAGUA GUA-F30P-3), and 5G* (5-GGAGGACGAA[MNa], 480.4; observed [MNa], 480.2.
AUGGUAGUAG CUGUAGUA-F30P-3), where F30P (5-dA21[C9]3-
dAdCdCP; C9, triethylene glycol phosphate; and P, CPG-puromycin;
Glen Research) serves as a flexible DNA linker. Templates were gelSynthesis of N-Nitroveratrylcarbonyl Phenylalanine
purified and desalted by ethanol precipitation, and subsequently,Cyanomethyl Ester
10 pmol of material was translated with 20 l tRNA-depleted rabbitApproximately 50 mg (300 mol) of L-phenylalanine was dissolved
reticulocyte lysate [23] prepared as previously described [11] inin 7.5 ml 35 mM Na2CO3  5 ml THF. To this was added 82.5 mg
the presence or absence of 80 pmol (2 g) aminoacylated-tRNA(300 mol) 4,5-dimethoxy-2-nitrobenzyl chloroformate in 5 ml THF.
(typically) at 30C for 60 min [11]. The translation reactions alsoThe reaction mixture was stirred at 25C for 2 hr then concentrated
contained 250 ng tRNAiMet [46], 1 l 200 mM creatine phosphate, 2by rotary evaporation. The crude product was then dissolved in 1.5
l [35S]methionine (10 mCi/mL; 1175.0 Ci/mmol; PerkinElmer Lifeml dry DMF and 1.5 ml chloroacetonitrile. To this was added 1 ml
Sciences, Inc), and 1 l SUPERase-In (Ambion) in a total volume(7.2 mmol) of dry TEA. The reaction mixture was stirred for 24 hr
of 30 L. It should be noted that amino acid supplementation inunder nitrogen at 25C. The reaction was concentrated under re-
translation reactions was limited to [35S]methionine only. mRNA-duced pressure, and the desired product was purified by silica gel
peptide fusion formation was stimulated by the addition of MgCl2chromatography in 95:5 CH2Cl2:EtOAc (Rf, 0.4). Product was ob-
and KCl to 50 mM and 0.6 M, respectively, prior to overnight incuba-tained as a yellow solid. Yield, 45% (54 mg). Analysis by low-resolu-
tion at 20C.tion ESI-MS: expected [MNa], 466.13; observed [MNa], 466.2.
The mRNA-peptide fusions were initially isolated from translation
reactions by dT25-cellulose (Pierce) binding in 5 ml isolation buffer
Synthesis of N-Methyl, N-Nitroveratrylcarbonyl (1M NaCl, 100 mM Tris-HCl [pH 8.0], 0.2% Triton X-100) at 4C for
Phenylalanine-dCA 45 min, washed in 700 l isolation buffer seven times at 4C, and
Commercially synthesized pdCpA was dissolved in 0.01 M tetrabu- eluted in 500l water (ambient temperature). Purified mRNA-peptide
tylammonium hydroxide and allowed to stand at 25C for 4 hr, then fusions were concentrated via ethanol precipitation in the presence
lyophilized to dryness. Lyophilized pdCpA (8 mol) was transferred of 30 g linear acrylamide (Ambion) and resuspended in the neces-
to a dry round-bottom flask, and N-methyl, N-nitroveratrylcarbonyl sary volume of TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA) to
phenylalanine cyanomethyl ester (18.3 mg [40 mol]) was added. achieve approximately 4000 cpm per 10 L.
The solid reagents were dissolved in 400 l dry DMF, and a catalytic
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